|
KMID : 1189420190320020094
|
|
Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology
2019 Volume.32 No. 2 p.94 ~ p.106
|
|
|
The Effects of Orally Administrated Gwakhyangjeonggi-san on DNCB-induced Atopic Dermatitis like Mice Model
|
|
Son Mi-Ju
Lee So-Min
Park Seong-Hwan
Kim Young-Eun
Jung Jee-Youn
|
|
|
Abstract
|
|
|
Objectives : This study was conducted to investigate the effects of Gwakhyangjeonggi-san(GJS) on atopic dermatitis(AD) induced by 2,4-dinitrochlorobenzene(DNCB) in mice.
Methods : The mice(Balb/c mice) were divided into three groups; normal Balb/c mice with oil treatment(Sham group), DNCB-induced AD mice(AD group), and GJS treated AD mice(GJS group). GJS group were orally administered GJS daily for 2 weeks. We observed changes of clinical skin severity score, the expression of thymic stromal lymphopoietin(TSLP), interleukin(IL)-4 and tumor necrosis factor(TNF)-α in skin and mast cell infiltration. Also, serum immunoglobulinE(IgE), IL-4, TNF-α and IL-6 were evaluated.
Results : The clinical skin severity score of GJS group was decreased compared to AD group. In hematoxylin and eosin staining results, GJS group showed a significant reduction of epithelial skin thickness. In addition, expression of TSLP and mast cell infiltration in skin were also reduced by GJS treatment compared to those of AD group. Thus, we evaluated expression of IL-4, Th2-dependent cytokine, and TNF-α, pro-inflammatory cytokine in skin. GJS significantly reduced both IL-4 and TNF-α compared to AD mice. Moreover, levels of IgE, IL-4, TNF-α and IL-6 in plasma also significantly decreased by oral GJS treatment.
Conclusion : The present study suggests that GJS can significantly reduced symptoms of AD, therefore it can be a promising candidate for anti-atopic dermatitis treatment.
|
|
|
KEYWORD
|
|
|
Atopic Dermatitis, Gwakhyangjeonggi-san, IL-4, in vivo, TNF-α
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|